Nasdaq Biotechnology Ishares (IBB) News $IBB 'Fast

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Nasdaq Biotechnology Ishares (IBB) News $IBB

'Fast Money' Recap: A Down Day
at The Street - Sat Mar 22, 4:00AM CDT
The trading panel discussed how investors are rotating out of high-growth stocks and into stocks like Microsoft and Cisco.

iShares Nasdaq Biotechnology Index Set to Possibly Rebound After Yesterday's Selloff of 4.74%
Comtex SmarTrend(R) - Fri Mar 21, 3:46PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $245.86 to a high of $260.30. Yesterday, the shares fell 4.7%, which took the trading range below the 3-day low of $256.42 on volume of 5.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Look for Shares of iShares Nasdaq Biotechnology Index to Potentially Rebound after Yesterday's 4.74% Sell Off
Comtex SmarTrend(R) - Fri Mar 21, 3:45PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $245.86 to a high of $260.30. Yesterday, the shares fell 4.7%, which took the trading range below the 3-day low of $256.42 on volume of 5.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

iShares Nasdaq Biotechnology Index Fund (IBB) : Short Sell @ $253.25
Trading Central - Fri Mar 21, 9:00AM CDT
From a technical view, the ETF has posted a reversal candlestick pattern on a weekly chart while biotechnology sector is in a parabolic rise. Regarding technical indicators, the weekly RSI has validated a bearish divergence in its overbought...

Is a Bubble Building in Large-Cap Biotechs?
Todd Campbell, The Motley Fool - Motley Fool - Tue Mar 18, 1:30PM CDT
The iShares Nasdaq Biotechnology ETF  has achieved an 81% return since February 2013, a return that trounces the S&P 500 index ETF's 26% return. By any measure, that's an astounding run, but does it signal a bubble has been built that's about to...

Stocks Edge Lower In Dull Session; Biogen Idec Hangs Tough
at Investor's Business Daily - Fri Mar 14, 1:51PM CDT
Stocks edged lower Friday in a listless session. With a little over one hour remaining in the session, all three major averages were down around 0.1%. Volume on the NYSE and Nasdaq volume was tracking slightly lower than Thursday's levels. In...

iShares Nasdaq Biotechnology Index Fund (IBB) : Take profit @ $254.52
Trading Central - Fri Mar 14, 10:41AM CDT
The ETF is close to its 50-day moving average which is acting as a support; we prefer to take profit right now at last price on short position opened on February 28th (+5.27%). Trading strategy: Close our short position at last price ($254.52).

iShares Nasdaq Biotechnology Index Set to Possibly Rebound After Yesterday's Selloff of 2.56%
Comtex SmarTrend(R) - Thu Mar 13, 3:59PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $253.05 to a high of $262.85. Yesterday, the shares fell 2.6%, which took the trading range below the 3-day low of $255.74 on volume of 2.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

OxySure's Improving Financials & Operational Milestones Paint a Bullish Picture
ACCESSWIRE - Mon Mar 10, 8:01AM CDT
Whitefish, MT / March 10, 2014 / The healthcare industry has been attracting record amounts of capital in 2014, driven by biotechnology and pharmaceutical companies bringing new products to market. In fact, more than half of all money flowing into U.S. sector-focused ETFs, or $4.06 billion through February 28th, was placed in healthcare ETFs, according to data compiled by Bloomberg.

Technical Analysis 101 - Trend, Trace, and Trigger - Analyst Blog
David Bartosiak - Zacks Investment Research - Thu Mar 06, 3:45PM CST
Three technical indicators to help determine the direction a stock is moving, potential areas of support and resistance, and when to buy.

SmarTrend Watching for Potential Rebound in Shares of iShares Nasdaq Biotechnology Index After 2.84% Loss
Comtex SmarTrend(R) - Fri Feb 28, 4:11PM CST
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $260.97 to a high of $273.02. Yesterday, the shares fell 2.8%, which took the trading range below the 3-day low of $269.14 on volume of 3.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

iShares Nasdaq Biotechnology Index Fund (IBB) : Short Sell @ $268.69
Trading Central - Fri Feb 28, 12:59PM CST
From a technical view, the ETF is posting a tentative reversal candlestick pattern on a weekly chart while biotechnology sector is in a parabolic rise. Regarding technical indicators, the weekly RSI is posting a tentative bearish divergence in its...

'Fast Money' Recap: A Stunning Move
at The Street - Tue Feb 25, 4:00AM CST
The trading panel discussed the S&P's move higher and how long that can last.

SmarTrend Watching for Potential Pullback in Shares of iShares Nasdaq Biotechnology Index After 1.25% Gain
Comtex SmarTrend(R) - Mon Feb 24, 4:39PM CST
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $270.01 to a high of $273.88. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $271.05 on volume of 1.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

iShares Nasdaq Biotechnology Index Rises 1.25% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Mon Feb 24, 4:39PM CST
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $270.01 to a high of $273.88. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $271.05 on volume of 1.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Bull of the Day: Alexion Pharma (ALXN) - Bull of the Day
Kevin Cook - Zacks Investment Research - Mon Feb 24, 2:33AM CST
Bull of the Day: Alexion Pharma (ALXN) - Bull of the Day

iShares Nasdaq Biotechnology Index Rises 2.61% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Tue Feb 18, 4:54PM CST
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $259.81 to a high of $264.58. Yesterday, the shares gained 2.6%, which took the trading range above the 3-day high of $260.94 on volume of 1.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Coventry's Jacobs Joins European Life Settlement Execs

Updated Category News Views 30

Neal Jacobs Steps Up in Life Settlements Coventry has added another feather to its cap with Neal Jacobs, their Senior Managing Director of Capital Markets, joining the Executive Committee of the European Life Settlement Association (ELSA). Elected at ELSA's Annual General Meeting on September 15, 2026, Jacobs brings a wealth of experience that promises to bolster the...

Continue Reading
New Data on SKYRIZI Offers Hope for Crohn's Patients

Updated Category News Views 28

Treating Crohn's: New Hope on the Horizon Folks, let me tell you, the landscape for treating Crohn's disease just got a bit more interesting. AbbVie's Phase 3 AFFIRM study has brought some attention-grabbing data on the table, showcasing the potential of their drug, SKYRIZI® (risankizumab-rzaa). This ain't just another run-of-the-mill study; these results could be a...

Continue Reading
Fluence Energy Faces Major Lawsuit Amid $3B Loss

Updated Category News Views 17

Securities Class Action: A Storm Brewing Just when you think you've got a grip on the market, a sharp right hook can come out of nowhere. Fluence Energy (NASDAQ:FLNC) is dealing with one of those punches now, getting dragged into the courtroom over claims they fudged financial lines. They hail innovation in energy storage, but shareholders are left shaking in their boots...

Continue Reading
Honeywell Aerospace Faces Legal Turbulence in Fraud Case

Updated Category News Views 12

If you've got your chips on Honeywell Aerospace, Inc. (HONA), buckle up because things are getting choppy. Investors who took a bath on their shares now have the chance to put on their legal gloves and join a securities fraud class action lawsuit against the company. Legal Storm Over Misleading Statements Here's the rub: Between June 29 and September 1, 2026, the folks at...

Continue Reading
Simple Home Upgrades That Boost Value Fast

Updated Category News Views 15

Transform Your Home's Curb Appeal Without Breaking The Bank Every homeowner knows that feeling when you look at your house one day and think, "This could use a little something." Say you're strolling through a neighborhood in Fulton, N.Y., and notice a gem. It's not a brand new build, but it gleams with character. You bet it's had a few smart touches that could apply...

Continue Reading
New American Funding Expands in Carolinas with Mullinix Move

Updated Category News Views 30

The Gathering of Mortgage Titans You don't just waltz into the mortgage world with a $2 billion track record and expect folks not to notice. Will Mullinix, a name that's become synonymous in the Carolinas with mortgage mastery, has decided to bring his influential Mullinix Mortgage Group under the banner of New American Funding. Talk about a power play. This bold strategy...

Continue Reading
Think Tank Pushes for Bold Parkinson's Prevention Plan

Updated Category News Views 27

A New Era for Parkinson's Disease Prevention The Parkinson's Foundation has rolled out its battle plan to take on Parkinson's disease from the ground up, shifting gears from managing symptoms to stopping the illness before it starts. It's about damn time, too. With the disease being the fastest-growing neurodegenerative disorder and impacting 10 million people worldwide,...

Continue Reading
Navigating Battery Compliance for AI Data Centers

Updated Category News Views 22

Untangling the Web of Global Battery Compliance Amid clamor about AI's insatiable appetite for energy storage, the rules around shipping, installing, and handling data center batteries have become a tangled web. From Waxahachie, Texas, Americase International plans to take the stage at the OCP Global Summit on October 15, 2026, to spearhead a discussion on bridging the...

Continue Reading
Paradigm Therapeutics: A Beacon in Rare Diseases

Updated Category News Views 4

A Step Towards Recognition You know the old saying: innovation never sleeps. Well, Paradigm Therapeutics seems to have taken that to heart. The company's embarked on a peculiar yet promising journey with SD-101 (Zorblesia™), and here they are, basking in the glow of another nomination for the 2026 Prix Galien USA "Best Start-Up" award. It’s their second shot at this...

Continue Reading
OmniActive's Fenavari: A New Era in Women's Health

Updated Category News Views 40

Pioneering Women's Health with Fenavari You ever wonder why some health products get all the hype? Here's one for the book: OmniActive Health Technologies launching Fenavari, their top-tier contender in the women's health market. Now, we're not talking your run-of-the-mill supplement here. We're stepping onto a new playing field, especially with Dr. Taz Bhatia stepping...

Continue Reading

Top 5 Most Recently Viewed Articles

Raytron's Innovative OGI Cameras Enhance Ozone Layer Protection

Updated Category News Views 194

Raytron's Commitment to Ozone Layer Preservation As the International Day for the Preservation of the Ozone Layer approaches, global attention focuses on looming threats to atmospheric recovery, particularly from greenhouse gases that continue to pose significant risks. While advancements have been made to eliminate CFCs under the Montreal Protocol, the ongoing rise in...

Continue Reading
Stocks Plunge Amid Weak Manufacturing Data and Concerns

Updated Category News Views 122

Market Overview and Reaction to Manufacturing Data In recent trading sessions, US stock indexes have experienced a notable decline, primarily due to disappointing manufacturing data that has raised concerns about the economy's health. The ISM Manufacturing index fell short of expectations, prompting investors to reevaluate their outlook as they prepare for the upcoming...

Continue Reading
Hisense Unveils Vision for a Brighter Future at CES 2026

Updated Category News Views 271

Hisense Showcases Human-Centric Technology at CES 2026 QINGDAO, China — Hisense, a prominent brand in consumer electronics and home appliances, is set to present its exciting vision at CES 2026. This year, Hisense aims to highlight a theme that resonates deeply with audiences: "Innovating A Brighter Life." This theme represents not just a slogan but a commitment to...

Continue Reading
Gilat's Recent Orders Highlight Demand for Satellite Solutions

Updated Category News Views 140

Gilat's Significant Orders for Satellite Technologies Gilat Satellite Networks Ltd. (NASDAQ: GILT, TASE: GILT) has made headlines with a remarkable achievement, securing over $25 million in orders from top-tier satellite operators worldwide. These orders underscore the growing demand for advanced satellite communications solutions, particularly in the rapidly expanding...

Continue Reading
Q.E.P. Co., Inc. Achieves Notable Financial Results in 2025

Updated Category News Views 259

Q.E.P. Co., Inc. Reports Impressive Fiscal 2025 Results Q.E.P. CO., INC. (OTCQX: QEPC) has shared its financial results for the fiscal year ending on February 28, 2025. This marks a significant moment for the Company following a comprehensive portfolio transformation initiated last year, which involved divesting from its Harris Flooring Group and international operations....

Continue Reading